Profile for Adaptimmune Therapeutics plc (ADAP)

$ 11.64 R     0.57 (+5.15%) Volume: 20.67m 4:00 PM EDT 1-Jun-2020
After Hours:  $ 11.57   -0.07 (-0.60%) Volume: 69.38k 7:57 PM EDT 1-Jun-2020
Business Description:
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.
Address: 60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY
Telephone: +44 1235430000 Website: http://www.adaptimmune.com
Facsimile: +44 1235430001 Email: [email protected]
Details
CEO: Adrian Rawcliffe
Employees: 400 Market Cap: 1.51b
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1621227
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: N/A
SIC: Pharmaceutical Preparations (2834)